Literature DB >> 14662263

Pulmonary thrombosis in adults with Eisenmenger syndrome.

Candice K Silversides1, John T Granton, Eli Konen, Michelle A Hart, Gary D Webb, Judith Therrien.   

Abstract

OBJECTIVES: We sought to determine the prevalence of pulmonary artery thrombosis in patients with Eisenmenger syndrome and to identify individuals at highest risk.
BACKGROUND: Eisenmenger syndrome is associated with pulmonary arterial thrombus formation. Both the prevalence and the determinants of pulmonary arterial thrombosis are unknown.
METHODS: This is a review of patients with Eisenmenger syndrome seen at the Toronto Congenital Cardiac Centre for Adults, Canada. Patients underwent a contrast-enhanced computed tomographic (CT) scan of the thorax.
RESULTS: Forty-nine consecutive patients with Eisenmenger syndrome were seen in our hospital. Fifteen patients did not undergo CT angiograms; therefore, 34 patients (mean age 42 +/- 10 years) were included in the study. Responsible shunts included ventricular septal defect (65%), atrial septal defect (15%), patent ductus arteriosus (9%), and other (11%). The prevalence of proximal pulmonary artery thrombus was 21% (7/34) of patients. Evidence of more distal vessel thrombosis was observed in 43% (3/7) of the patients who had visible thrombus in the proximal pulmonary arteries. Patients with thrombus were more likely to be female (86% vs. 37%, p = 0.04) and to have lower oxygen saturations (72% +/- 9% vs. 85% +/- 6%, p = 0.01). Differences in functional status did not identify patients at highest risk for thrombosis.
CONCLUSIONS: Patients with Eisenmenger syndrome have a substantial risk of pulmonary artery thrombus formation. Women and patients with lower oxygen saturations are at the highest risk of developing thrombosis. In the context of an increased bleeding tendency in these patients, the role of anticoagulation treatment needs to be determined.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662263     DOI: 10.1016/j.jacc.2003.07.022

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  22 in total

Review 1.  Choosing the best contraceptive method for the adult with congenital heart disease.

Authors:  Candice K Silversides; Mathew Sermer; Samuel C Siu
Journal:  Curr Cardiol Rep       Date:  2009-07       Impact factor: 2.931

Review 2.  Management of acute heart failure in adult patients with congenital heart disease.

Authors:  Alexander Van De Bruaene; Lukas Meier; Walter Droogne; Pieter De Meester; Els Troost; Marc Gewillig; Werner Budts
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

3.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: complex congenital cardiac lesions.

Authors:  Candice K Silversides; Omid Salehian; Erwin Oechslin; Markus Schwerzmann; Isabelle Vonder Muhll; Paul Khairy; Eric Horlick; Mike Landzberg; Folkert Meijboom; Carole Warnes; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

4.  Clinical experience of chest pain in adults with congenital heart disease in a single tertiary center.

Authors:  June Huh; I-Seok Kang; Heung Jae Lee; Seung Woo Park
Journal:  Pediatr Cardiol       Date:  2010-02-09       Impact factor: 1.655

5.  Massive epistaxis in a patient with Eisenmenger syndrome: illustrating the clot-versus-bleed conundrum.

Authors:  Alexander Liu; Harman Saman; Pawan Pusalkar
Journal:  BMJ Case Rep       Date:  2011-08-04

Review 6.  Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?

Authors:  Ian C Scott; Samantha L Hider; David L Scott
Journal:  Drug Saf       Date:  2018-07       Impact factor: 5.606

7.  Massive pulmonary artery thrombosis with haemoptysis in adults with Eisenmenger's syndrome: a clinical dilemma.

Authors:  C Broberg; M Ujita; S Babu-Narayan; M Rubens; S K Prasad; J S R Gibbs; M A Gatzoulis
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

Review 8.  Insight into Pulmonary Arterial Hypertension Associated with Congenital Heart Disease (PAH-CHD): Classification and Pharmacological Management from a Pediatric Cardiological Point of View.

Authors:  I-Chen Chen; Zen-Kong Dai
Journal:  Acta Cardiol Sin       Date:  2015-11       Impact factor: 2.672

9.  Case 1/2016--56-Year-Old Male with Atrial Septal Defect, Pulmonary Arterial Hypertension, Hospitalized Due to Eisenmenger Syndrome.

Authors:  Carolina Santana; Antonio Augusto B Lopes; Antonio Fernando Lins de Paiva; Luiz Alberto Benvenuti
Journal:  Arq Bras Cardiol       Date:  2016-03       Impact factor: 2.000

10.  Pulmonary hypertension in adult congenital heart disease.

Authors:  Josanna Rodriguez-Lopez
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.